Home LiteratureArticle Details
PMID: 10854219 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells.

The American journal of pathology ·Vol. 156 ·No. 6 ·2000-06-00 ·Pages 1961-71

Mercader M, Taddeo B, Panella JR, Chandran B, Nickoloff BJ, Foreman KE

Abstract

Human herpesvirus 8 (HHV-8) is a gamma2-herpesvirus consistently identified in Kaposi's sarcoma (KS), primary effusion lymphoma, and multicentric Castleman's disease. Although HHV-8 infection appears to be necessary, it may not be sufficient for development of KS without the involvement of other cofactors. One potentially important cofactor is HIV-1. HIV-1-infected cells produce HIV-1-related proteins and cytokines, both of which have been shown to promote growth of KS cells in vitro. Though HIV-1 is not absolutely necessary for KS development, KS is the most frequent neoplasm in AIDS patients, and AIDS-KS is recognized as a particularly aggressive form of the disease. To determine whether HIV-1 could participate in the pathogenesis of KS by modulating HHV-8 replication (rather than by inducing immunodeficiency), HIV-1-infected T cells were cocultured with the HHV-8-infected cell line, BCBL-1. The results demonstrate soluble factors produced by or in response to HIV-1-infected T cells induced HHV-8 replication, as determined by production of lytic phase mRNA transcripts, viral proteins, and detection of progeny virions. By focusing on cytokines produced in the coculture system, several cytokines known to be important in growth and proliferation of KS cells in vitro, particularly Oncostatin M, hepatocyte growth factor/scatter factor, and interferon-gamma, were found to induce HHV-8 lytic replication when added individually to BCBL-1 cells. These results suggest specific cytokines can play an important role in the initiation and progression of KS through reactivation of HHV-8. Thus, HIV-1 may participate more directly than previously recognized in KS by promoting HHV-8 replication and, hence, increasing local HHV-8 viral load.

MeSH Terms
Coculture Techniques Cytokines/physiology HIV Infections/metabolism,pathology HIV-1 Herpesvirus 8, Human/physiology Humans Inflammation Mediators/physiology T-Lymphocytes/metabolism Tumor Cells, Cultured Virus Replication
Chemicals
Cytokines Inflammation Mediators
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Mercader M
Department of Pathology and Skin Cancer Research Laboratories, Loyola University Medical Center, Maywood, IL 60153-5385, USA.
Taddeo B
Panella J R
Chandran B
Nickoloff B J
Foreman K E
References (69)
69 references, click to expand
  1. Antibodies against human herpesvirus 8 in black South African patients with cancer.
    N Engl J Med. 1999 Jun 17;340(24):1863-71 PMID: 10369849
  2. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.
    Blood. 1999 Jun 15;93(12):4044-58 PMID: 10361101
  3. Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.
    J Virol. 1999 Jul;73(7):5894-902 PMID: 10364341
  4. Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies.
    Virology. 1999 Sep 15;262(1):237-49 PMID: 10489357
  5. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?
    Lancet. 1990 Jan 20;335(8682):123-8 PMID: 1967430
  6. Utilizing uracil DNA glycosylase to control carryover contamination in PCR: characterization of residual UDG activity following thermal cycling.
    Biotechniques. 1992 Aug;13(2):180-4 PMID: 1389144
  7. Clinical aspects of Kaposi's sarcoma.
    Curr Opin Oncol. 1992 Oct;4(5):867-74 PMID: 1457502
  8. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.
    J Virol. 1993 Jan;67(1):277-87 PMID: 8416373
  9. Human B cell lines express the interferon gamma gene.
    Cytokine. 1992 Nov;4(6):454-60 PMID: 1292629
  10. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
    Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7941-5 PMID: 7690138
  11. Disseminated Kaposi's sarcoma in homosexual men.
    Ann Intern Med. 1982 Jun;96(6 Pt 1):693-700 PMID: 6283973
  12. Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma.
    J Biol Response Mod. 1985 Aug;4(4):358-64 PMID: 3928825
  13. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.
    Cell. 1986 Mar 28;44(6):941-7 PMID: 2420471
  14. Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon.
    Onkologie. 1986 Jun;9(3):163-6 PMID: 3018647
  15. Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma.
    Cancer Res. 1986 Dec;46(12 Pt 1):6333-8 PMID: 3022918
  16. Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.
    Science. 1988 Oct 21;242(4877):426-30 PMID: 3262925
  17. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.
    Science. 1989 Jan 13;243(4888):223-6 PMID: 2643161
  18. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma.
    J Acquir Immune Defic Syndr. 1989;2(1):54-8 PMID: 2918461
  19. Analysis of human KS biopsies and cloned cell lines for cytomegalovirus, HIV-1, and other selected DNA virus sequences.
    AIDS Res Hum Retroviruses. 1989 Apr;5(2):225-31 PMID: 2540783
  20. Rapid, reversible staining of northern blots prior to hybridization.
    Biotechniques. 1988 Mar;6(3):196-7, 199-200 PMID: 2483319
  21. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions.
    Gene. 1990 Sep 1;93(1):125-8 PMID: 2227421
  22. Pathogenesis of AIDS-associated Kaposi's sarcoma.
    Hematol Oncol Clin North Am. 1991 Apr;5(2):281-95 PMID: 2022594
  23. Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions.
    J Clin Invest. 1991 Jul;88(1):174-85 PMID: 1676036
  24. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.
    Science. 1992 Mar 13;255(5050):1432-4 PMID: 1542793
  25. Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma.
    Adv Exp Med Biol. 1991;303:27-38 PMID: 1805571
  26. Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation.
    Blood. 1992 Aug 1;80(3):724-32 PMID: 1322203
  27. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma.
    Immunol Rev. 1992 Jun;127:147-55 PMID: 1506004
  28. Three-dimensional laser-scanning confocal microscopy of in situ hybridization in the skin.
    Am J Dermatopathol. 1994 Feb;16(1):44-51 PMID: 8160929
  29. Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5281-5 PMID: 7515495
  30. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.
    Am J Pathol. 1994 Jul;145(1):74-9 PMID: 8030759
  31. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
    Science. 1994 Dec 16;266(5192):1865-9 PMID: 7997879
  32. Role of HIV-1 Tat in the pathogenesis of AIDS-associated Kaposi's sarcoma.
    Antibiot Chemother (1971). 1994;46:62-72 PMID: 7826041
  33. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma.
    Lancet. 1995 Mar 25;345(8952):759-61 PMID: 7891487
  34. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
    J Immunol. 1995 Apr 1;154(7):3582-92 PMID: 7897237
  35. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection.
    N Engl J Med. 1995 May 4;332(18):1181-5 PMID: 7700310
  36. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
    J Clin Invest. 1995 Apr;95(4):1723-34 PMID: 7535796
  37. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma.
    Lancet. 1995 Apr 22;345(8956):1043-4 PMID: 7723505
  38. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients.
    Science. 1995 Apr 28;268(5210):582-3 PMID: 7725108
  39. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.
    BMJ. 1995 Jul 15;311(6998):156-8 PMID: 7613426
  40. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences.
    Blood. 1995 Oct 1;86(7):2708-14 PMID: 7670109
  41. Kaposi's sarcoma and KSHV.
    Lancet. 1995 Nov 18;346(8986):1359 PMID: 7475782
  42. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.
    Nat Med. 1995 Dec;1(12):1274-8 PMID: 7489408
  43. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae.
    J Virol. 1996 Jan;70(1):549-58 PMID: 8523568
  44. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.
    Nat Med. 1996 Mar;2(3):342-6 PMID: 8612236
  45. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
    N Engl J Med. 1996 May 16;334(20):1292-7 PMID: 8609946
  46. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
    N Engl J Med. 1996 Jul 25;335(4):233-41 PMID: 8657239
  47. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.
    J Exp Med. 1996 Jul 1;184(1):283-8 PMID: 8691144
  48. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission.
    Nat Med. 1996 Aug;2(8):918-24 PMID: 8705863
  49. Kaposi's sarcoma tumor cells preferentially express Bcl-xL.
    Am J Pathol. 1996 Sep;149(3):795-803 PMID: 8780384
  50. Pathogenesis of AIDS--related Kaposi's sarcoma.
    Oncology (Williston Park). 1996 Mar;10(3):335-41; discussion: 342-50 PMID: 8820448
  51. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
    Lancet. 1996 Sep 28;348(9031):858-61 PMID: 8826812
  52. The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery.
    AIDS. 1996;10 Suppl A:S51-7 PMID: 8883610
  53. HIV-1 and Kaposi's sarcoma.
    Eur J Cancer Prev. 1996 Oct;5(5):410-2 PMID: 8972281
  54. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma.
    N Engl J Med. 1997 Jan 16;336(3):163-71 PMID: 8988896
  55. Activation of HHV-8 by HIV-1 tat.
    Lancet. 1997 Mar 15;349(9054):774-5 PMID: 9074581
  56. Open reading frame 26 of human herpesvirus 8 encodes a tetradecanoyl phorbol acetate- and butyrate-inducible 32-kilodalton protein expressed in a body cavity-based lymphoma cell line.
    J Virol. 1997 Jun;71(6):4791-7 PMID: 9151873
  57. In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma.
    J Clin Invest. 1997 Jun 15;99(12):2971-8 PMID: 9185521
  58. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma.
    Int J Cancer. 1997 Jul 3;72(1):68-71 PMID: 9212225
  59. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1).
    J Virol. 1998 Feb;72(2):1005-12 PMID: 9444993
  60. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody.
    Virology. 1998 Jan 5;240(1):118-26 PMID: 9448696
  61. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
    Arch Intern Med. 1998 Mar 9;158(5):491-7 PMID: 9508227
  62. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8).
    J Gen Virol. 1998 Jul;79 ( Pt 7):1573-91 PMID: 9680119
  63. Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma.
    J Natl Cancer Inst Monogr. 1998;(23):55-7 PMID: 9709304
  64. Geographically distinct HHV-8 DNA sequences in Saudi Arabian Iatrogenic Kaposi's sarcoma lesions.
    Am J Pathol. 1998 Sep;153(3):1001-4 PMID: 9736049
  65. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus.
    J Virol. 1998 Oct;72(10):8309-15 PMID: 9733875
  66. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts.
    Virology. 1998 Sep 15;249(1):140-9 PMID: 9740785
  67. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells.
    J Gen Virol. 1999 Jan;80 ( Pt 1):83-90 PMID: 9934688
  68. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.
    J Hum Virol. 1998 Mar-Apr;1(3):193-9 PMID: 10195242
  69. Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study.
    Leukemia. 1999 Apr;13 Suppl 1:S110-2 PMID: 10232382
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2000-06-00
Pages
1961-71
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1850066
Subset
IM
Grants
NCI NIH HHS · R01 CA075911 · United States
NCI NIH HHS · CA63928 · United States
NCI NIH HHS · CA75893 · United States
NCI NIH HHS · CA76951 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com